Skip to main content
SpringerLink
Log in

Who Uses Streptokinase vs Alteplase (t-PA), and Why?

  • Current Comment
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Brody B, Wray N, Bame S, Petersen N, Harward M. The impact of economic considerations on clinical decision making: the case of thrombolytic therapy. Medical Care 29(9): 899–910, 1991

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacoeconomic Research, Brigham and Women’s Hospital, Boston, Massachusetts, USA

    Lisa A. Sanchez (Manager)

Authors
  1. Lisa A. Sanchez
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanchez, L.A. Who Uses Streptokinase vs Alteplase (t-PA), and Why?. PharmacoEconomics 2, 428–429 (1992). https://doi.org/10.2165/00019053-199202050-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199202050-00012

Keywords

Search

Navigation